OTC: NWBO - Northwest Biotherapeutics, Inc.

半年間の収益性: -34.79%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Northwest Biotherapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors.

さらに詳しく
The company was founded in 1996 and is headquartered in Bethesda, Maryland.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

ISIN US66737P6007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nwbio.com
Цена ао 0.53
1日あたりの価格変動: +1.44% (0.27)
週ごとの価格変動: +5.35% (0.26)
月ごとの料金変更: -2.18% (0.28)
3ヶ月間の価格変動: -14.41% (0.32)
半年間の価格変動: -34.79% (0.42)
年間の価格変動: -60.87% (0.7)
3年間の価格推移: -59.72% (0.68)
5年間の価格推移: +21.73% (0.225)
10年間の価格推移: 0% (0.2739)
年初からの価格変動: -8.7% (0.3)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 456.31 1
P/BV -13.4 0
P/E 0 0
EV/EBITDA -9.03 0
合計: 2

効率

名前 意味 学年
ROA, % -224.65 0
ROE, % 95.17 10
合計: 1.67

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.4184 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % -19.5 0
収益性 Ebitda, % 296.2 10
収益性 EPS, % 61.38 8
合計: 7.2
さらに詳しく

機関 音量 共有, %
Moloney Securities Asset Management, LLC 358160 0.03
Opus Capital Group, LLC 60150 0.01
Williams Jones Wealth Management, LLC. 44000 0
Lee, Danner & Bass, Inc. 20000 0
MAI Capital Management 20000 0
Advisors Management Group, Inc. 10270 0
Bartlett & Co. 4292 0
Bartlett & Co. Wealth Management LLC 4292 0
Coston, McIsaac & Partners 1000 0



スーパーバイザー 役職 支払い 生年
Ms. Linda F. Powers J.D. Chairperson, CEO, President, CFO & Chief Accounting Officer 925k 1956 (69 年)
Dr. Alton L. Boynton Ph.D. Founder, Chief Scientific Officer, Secretary & Director 375k 1945 (80 年)
Dr. Marnix L. Bosch M.B.A., Ph.D. Chief Technical Officer 453.6k 1959 (66 年)
Mr. Leslie J. Goldman Senior VP & General Counsel 725k 1945 (80 年)
Mr. David Innes Vice President of Investor Relations N/A

住所: United States, Bethesda. MD, 4800 Montgomery Lane - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.nwbio.com